Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Medico Intercontinental's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medico Intercontinental Buyback Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Medico Intercontinental's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Medico Intercontinental's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medico Intercontinental (BOM:539938) has a Buyback Yield % of 0.00 as of Aug. 24, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medico Intercontinental and its competitors. According to the industry distribution chart, Medico Intercontinental ranks #999999 out of 243 companies in the Drug Manufacturers industry.
Is Medico Intercontinental's Buyback Yield % too high?
Medico Intercontinental's current Buyback Yield % is 0.00. Based on the distribution chart, Medico Intercontinental ranks #999999 out of 243 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Medico Intercontinental has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medico Intercontinental's Buyback Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Medico Intercontinental ranks #999999 out of 243 companies for Buyback Yield %. This places Medico Intercontinental in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medico Intercontinental and its competitors. Medico Intercontinental's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medico Intercontinental stock overvalued right now?
Based on GuruFocus' analysis, Medico Intercontinental (BOM:539938) is currently considered Possible Value Trap. The stock's GF Value™ is ₹45.16, compared to a current price of ₹28.72 — trading 36.4% below its estimated fair value. The current Buyback Yield % is 0.00. Medico Intercontinental's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Medico Intercontinental (BOM:539938), the current Buyback Yield % is 0.00 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medico Intercontinental (BOM:539938) Overvalued in 2026?
Based on GuruFocus' analysis, Medico Intercontinental stock appears to be undervalued.
The current stock price of ₹28.72 is trading 36.4% below its estimated GF Value™ of ₹45.16.
GuruFocus considers Medico Intercontinental to be Possible Value Trap.
Key valuation signals for BOM:539938:
Buyback Yield %: 0.00
GF Value™: ₹45.16 vs. price of ₹28.72 (36.4% below fair value)
No single metric tells the full story. See the BOM:539938 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medico Intercontinental Ltd provides services to biopharmaceuticals companies. The company's operating segment includes Trading of pharmaceuticals products. The company product includes General Range, Derma Range, Psychiatric range, Eye drops among others.
53GF Score
Get the complete analysis for BOM:539938
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539938 has been successfully added to your 
